Off-label use of 5HT3 antagonists: clinical evidence and guidelines
CADTH
Record ID 32015000232
English
Authors' recommendations:
Four systematic reviews, six randomized controlled trials, three non-randomized studies, and one evidence-based guideline were identified regarding long term (over 5 day) 5HT3 antagonist use for indications other than nausea and vomiting.
Details
Project Status:
Completed
Year Published:
2014
URL for published report:
http://www.cadth.ca/media/pdf/htis/sep-2014/RA0684%20Off-label%205HT3%20Use%20Final.pdf
English language abstract:
An English language summary is available
Publication Type:
Not Assigned
Country:
Canada
MeSH Terms
- Antiemetics
- Serotonin 5-HT3 Receptor Antagonists
- Off-Label Use
Contact
Organisation Name:
Canadian Agency for Drugs and Technologies in Health
Contact Address:
600-865 Carling Avenue, Ottawa, ON K1S 5S8 Canada. Tel: +1 613 226 2553; Fax: +1 613 226 5392;
Contact Name:
requests@cadth.ca
Contact Email:
requests@cadth.ca
Copyright:
Canadian Agency for Drugs and Technologies in Health (CADTH)
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.